K Number
K150084
Device Name
Argyle¿ Polyvinyl Chloride (PVC) and Kangaroo¿ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit connector
Manufacturer
Date Cleared
2015-07-13

(179 days)

Product Code
Regulation Number
876.5980
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit connector are intended for enteral feeding to deliver enteral nutrition, liquid or medication to patient from an enteral feeding syringe or feeding set designed with a connector for enteral applications. The device is intended for pediatric patients who require enteral feeding.
Device Description
The Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit Connector are sterile, disposable medical devices designed to deliver nutrition to patients who cannot obtain nutrition by mouth, are unable to chew or swallow safely, or need nutritional supplementation. The device is designed with a single lumen Polyvinyl Chloride (PVC) or Polyurethane (PU) tubes with ENFit male small bore connector at proximal end.
More Information

Not Found

No
The summary describes a physical medical device (feeding tube) and its performance testing, with no mention of software, algorithms, or AI/ML capabilities.

Yes
The device is described as delivering nutrition, liquid, or medication to patients, which classifies it as having a therapeutic function.

No

The device is described as an enteral feeding tube used to deliver nutrition, liquid, or medication. It does not perform any diagnostic function.

No

The device description clearly states it is a physical medical device (feeding tubes made of PVC or PU) and the performance studies involve testing of physical properties and connectors, not software.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for "enteral feeding to deliver enteral nutrition, liquid or medication to patient". This involves delivering substances into the body, not analyzing samples from the body to diagnose a condition.
  • Device Description: The description details a tube designed for delivering substances, not for collecting or analyzing biological samples.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any diagnostic purpose.

IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device's function is purely for delivering substances for nutritional support.

N/A

Intended Use / Indications for Use

The Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit connector are intended for enteral feeding to deliver enteral nutrition, liquid or medication to patient from an enteral feeding syringe or feeding set designed with a connector for enteral applications.

The device is intended for pediatric patients who require enteral feeding.

Product codes

PIF

Device Description

The Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit Connector are sterile, disposable medical devices designed to deliver nutrition to patients who cannot obtain nutrition by mouth, are unable to chew or swallow safely, or need nutritional supplementation. The device is designed with a single lumen Polyvinyl Chloride (PVC) or Polyurethane (PU) tubes with ENFit male small bore connector at proximal end.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

pediatric patients

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

  • Biocompatibility testing has demonstrated the biological safety of parts of the proposed feeding tubes which directly contact the patient.
  • Stability testing evaluated the properties of the proposed Feeding Tubes after accelerated aging in support of the product expiration date.
  • Dimensional analysis was conducted for critical dimensions of the proposed Feeding Tubes, in accordance with ISO 80369-3, Small-bore connectors for liquids and gases in healthcare applications - Part 3: Connectors for enteral applications. The testing demonstrates the proposed devices conform to the criteria in Table B.2 of ISO 80963-3.
  • Study performed on the proposed Feeding Tubes with ENFit Connector included the tests listed below, in accordance with ISO 80369-3, Small- bore connectors for liquids and gases in healthcare applications - Part 3: Connectors for enteral applications, using the test methods provided in ISO 80369-20, Small-bore connectors for liquids and gases in healthcare applications - Part 20: Common test methods. The testing demonstrates the proposed devices conform to the requirements of ISO 80963-3.
    • Fluid Leakage; Requirement Defined in ISO80369-3: Clause 6.2; Test Method Defined in ISO 80369-20: Annex C
    • Stress Cracking; Requirement Defined in ISO80369-3: Clause 6.3; Test Method Defined in ISO 80369-20: Annex E
    • Resistance to separation from axial load; Requirement Defined in ISO80369-3: Clause 6.4; Test Method Defined in ISO 80369-20: Annex F
    • Resistance to separation from unscrewing; Requirement Defined in ISO80369-3: Clause 6.5; Test Method Defined in ISO 80369-20: Annex G
    • Resistance to overriding; Requirement Defined in ISO80369-3: Clause 6.6; Test Method Defined in ISO 80369-20: Annex H
    • Disconnection by unscrewing; Requirement Defined in ISO80369-3: Clause 6.7; Test Method Defined in ISO 80369-20: Annex I
  • Flow testing was conducted and has demonstrated that the proposed feeding tubes are substantially equivalent to the performance of the predicate device.
  • Liquid Leakage
  • Tensile Strength
  • The risk associated with the misconnection of the ENFit connector has been assessed.
    • ENFit Misconnection Data with Failure Modes and Effects Analysis (FMEA)
    • Enteral Connector Misconnection Assessment
    • Enteral Connection Risk Management Report
    • ENFit Misconnection Risk Assessment Report
  • Human Factors Validation Study

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K820441, K820442

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 876.5980 Gastrointestinal tube and accessories.

(a)
Identification. A gastrointestinal tube and accessories is a device that consists of flexible or semi-rigid tubing used for instilling fluids into, withdrawing fluids from, splinting, or suppressing bleeding of the alimentary tract. This device may incorporate an integral inflatable balloon for retention or hemostasis. This generic type of device includes the hemostatic bag, irrigation and aspiration catheter (gastric, colonic, etc.), rectal catheter, sterile infant gavage set, gastrointestinal string and tubes to locate internal bleeding, double lumen tube for intestinal decompression or intubation, feeding tube, gastroenterostomy tube, Levine tube, nasogastric tube, single lumen tube with mercury weight balloon for intestinal intubation or decompression, and gastro-urological irrigation tray (for gastrological use).(b)
Classification. (1) Class II (special controls). The barium enema retention catheter and tip with or without a bag that is a gastrointestinal tube and accessory or a gastronomy tube holder accessory is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I (general controls) for the dissolvable nasogastric feed tube guide for the nasogastric tube. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 876.9.

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing right, with flowing lines representing hair or clothing.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

July 13, 2015

Covidien Sona Manickam Senior Regulatory Affairs Specialist 15 Hampshire Street Mansfield, MA 02048

Re: K150084

Trade/Device Name: Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit connector Regulation Number: 21 CFR §876.5980 Regulation Name: Gastrointestinal tube and accessories Regulatory Class: II Product Code: PIF Dated: June 12, 2015 Received: June 15, 2015

Dear Sona Manickam,

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

1

You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Benjamin R. Fisher -S

Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K150084

Device Name

Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit connector

Indications for Use (Describe)

The Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit connector are intended for enteral feeding to deliver enteral nutrition, liquid or medication to patient from an enteral feeding syringe or feeding set designed with a connector for enteral applications.

The device is intended for pediatric patients who require enteral feeding.

Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D)□ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

2.0 510(k) Summary

Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit Connector

In accordance with section 513(i) of the SMDA and as defined in 21CFR Part 807.92 this summary is submitted by:

Covidien 15 Hampshire Street Mansfield, MA 02048 Date Prepared: July 09, 2015

a. Contact Person

Sona Manickam Senior Regulatory Affairs Specialist Covidien Telephone: (508) 261-8147 Fax: (508) 261-8461

  • b. Name of Medical Device
    Common Name: tube, feeding

U.S. FDA Classification Product Code: PIF

U.S. Regulation Description: Gastrointestinal tube and accessories, 21 CFR 876.5980

Proprietary / Trade Name: Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit Small Bore Connector

  • c. Identification of Legally Marketed Device(s)
    Argyle Polyvinyl Chloride (PVC) Feeding Tubes, K820441 Argyle Indwell Polyurethane Feeding Tubes, K820442

d. Device Brief Description

The Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit Connector are sterile, disposable medical devices designed to deliver nutrition to patients who cannot obtain nutrition by mouth, are unable to chew or swallow safely, or need nutritional supplementation. The device is designed with a single lumen Polyvinyl Chloride (PVC) or Polyurethane (PU) tubes with ENFit male small bore connector at proximal end.

4

e. Device Intended Use

The Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit connector are intended for enteral feeding to deliver enteral nutrition, liquid or medication to patient from an enteral feeding syringe or feeding set designed with a connector for enteral applications.

The device is intended for pediatric patients who require enteral feeding.

  • f. Product Comparison Summary
    The proposed and predicate enteral feeding devices are all intended for pediatric patients who require enteral feeding due to illness which prevents normal chewing and swallowing. These products have the same intended use, the same function, and the same general technological characteristics. The majority of the parts for both the proposed and predicate feeding tubes are made with the same material. The variation of the materials for certain components has been proven biocompatible and effective. The major technological enhancement is the incorporation of new ENFit connector which is compliant to ISO 80369-3, in the proposed Feeding Tubes. A male ENFit connector is offered for the proposed feeding tubes. Other additions to the proposed products include additional Fr sizes in both PVC and Polyurethane feeding tubes and an added length to the Polyurethane feeding tubes. These variations do not alter the intended use of the device, nor impact the safety and effectiveness of the product.

  • g. Nonclinical testing

    • Biocompatibility testing has demonstrated the biological safety of parts of the proposed feeding tubes which directly contact the patient.
    • . Stability testing evaluated the properties of the proposed Feeding Tubes after accelerated aging in support of the product expiration date.
    • Dimensional analysis was conducted for critical dimensions of the proposed Feeding Tubes, in accordance with ISO 80369-3, Small-bore connectors for liquids and gases in healthcare applications - Part 3: Connectors for enteral applications. The testing demonstrates the proposed devices conform to the criteria in Table B.2 of ISO 80963-3.
    • Study performed on the proposed Feeding Tubes with ENFit Connector included the ● tests listed below, in accordance with ISO 80369-3, Small- bore connectors for liquids and gases in healthcare applications - Part 3: Connectors for enteral applications, using the test methods provided in ISO 80369-20, Small-bore connectors for liquids and gases in healthcare applications - Part 20: Common test methods. The testing demonstrates the proposed devices conform to the requirements of ISO 80963-3.

5

| Individual Test Defined
in ISO 80369-3 | Requirement Defined
in ISO80369-3 | Test Method Defined
in ISO 80369-20 |
|---------------------------------------------|--------------------------------------|----------------------------------------|
| Fluid Leakage | Clause 6.2 | Annex C |
| Stress Cracking | Clause 6.3 | Annex E |
| Resistance to separation
from axial load | Clause 6.4 | Annex F |
| Resistance to separation
from unscrewing | Clause 6.5 | Annex G |
| Resistance to overriding | Clause 6.6 | Annex H |
| Disconnection by
unscrewing | Clause 6.7 | Annex I |

  • Flow testing was conducted and has demonstrated that the proposed feeding tubes are ● substantially equivalent to the performance of of the predicate device.
  • Liquid Leakage ●
  • Tensile Strength ●
  • The risk associated with the misconnection of the ENFit connector has been assessed.
    • ENFit Misconnection Data with Failure Modes and Effects 트 Analysis (FMEA)
    • l Enteral Connector Misconnection Assessment
    • l Enteral Connection Risk Management Report
    • I ENFit Misconnection Risk Assessment Report
  • Human Factors Validation Study ●

h. Clinical testing

Clinical evaluations were not relied upon for the determination of substantial equivalence to the predicate device based on the device classification, sufficient safety and functional performance information provided in the submission.

  • i. Conclusions
    This information provided within this pre-market notification demonstrates that the Argyle™ Polyvinyl Chloride (PVC) and Kangaroo™ Polyurethane (PU) Neonatal and Pediatric Feeding Tubes with ENFit Connector have no difference that would affect the safety or effectiveness of the devices as compared to the predicate devices and demonstrate substantial equivalency.

End of Summary